# Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

> **NCT04359953** · PHASE3 · TERMINATED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 16 (actual)

## Conditions studied

- COVID-19 Infection

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Azithromycin
- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT04359953
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-25
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** difficulty in recruiting
- **Last updated:** 2022-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04359953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04359953, "Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04359953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*